Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis. - Wikidata - thesis-toulmin - TriplyDB

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

http://www.wikidata.org/entity/Q30412709

about

Analysis of molecular mechanisms of 5-fluorouracil-induced steatosis and inflammation in vitro and in mice State-of-the-art cross-sectional liver imaging: beyond lesion detection and characterization.

P2860

Q37706542-40B31B52-AEF6-430C-B938-CF66ABAEA299 Q38923545-2C17CD86-A60B-4D55-B6C6-D667445BD661

P2860

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

http://www.wikidata.org/entity/Q30412709

description

2014 nî lūn-bûn

@nan

2014 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@ast

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@en

type

label

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@ast

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@en

prefLabel

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@ast

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@en

P1433

Q30412709-97487E2C-18A7-4FEE-91BF-9A19F05E35F7

P1476

Q30412709-2ADEA69F-DA96-464C-B4F7-F5D44400E811

P2093

Q30412709-393E9C19-B93E-426D-A95F-7A8E26434A7B

Q30412709-60D807F1-965C-4343-89DC-8FF6CEE1FF8C

Q30412709-807C84F7-0D05-4A95-BD6F-40F9B77525E6

Q30412709-B42AB5B0-6AEB-4A39-A062-391891A9E296

Q30412709-B65B7159-E923-463F-8B6E-2AEE4914AABB

Q30412709-BB04C212-E54A-4AAC-A41D-651C3C96F0E8

Q30412709-BDF27AA0-0C19-40C1-9394-B6735B4DA2CF

Q30412709-D3FF60BA-57CB-4F57-8551-41CECD6C62B6

Q30412709-D6D96F2F-DF2A-488B-9B73-B41AFF5485C3

P2860

Q30412709-0144F2B9-D6B7-4C32-9964-5DA92F31AD7C

Q30412709-0982FF08-4E51-4BDD-9529-1B1E8BB52A6E

Q30412709-164A87F8-50ED-41B8-BAED-1806080C3996

Q30412709-1BA3A410-3F68-4978-9DA5-E34208FCD14C

Q30412709-367C7541-F364-4212-B748-AE1666C012DF

Q30412709-42D5305A-34AC-42B4-88F6-BA203EC6325B

Q30412709-4459A339-CE84-4580-9844-FF343F6C199B

Q30412709-494495B0-8F9C-408B-B9FD-7D74A38FE736

Q30412709-52591305-8230-4118-94C3-9A90C3EE8956

Q30412709-53BFCB2B-05E6-46DC-BDD3-C450E1F10503

P2888

Q30412709-E151DB82-04BA-4EAA-B962-6FE03525B824

P304

Q30412709-4CAAD235-0CCD-4308-B73F-949B580AF2C6

P31

Q30412709-9F53CC98-83A7-4CB0-8B61-38B2AE6F5F45

P356

Q30412709-1FB52998-C8F7-45A3-8E3E-19F496A808BE

P433

Q30412709-A8D167E8-C083-479A-97C4-E074B24A3390

P478

Q30412709-A8176605-3066-42BC-821F-204F5EEAE5FA

P577

Q30412709-67F71CAA-7C79-46EE-9C47-0EB3F8FA4B27

P6179

Q30412709-AD4FBC29-D4AF-48D0-874D-C34275E807E9

P698

Q30412709-400E07D2-A1B0-40F6-B31A-FC5ADDBFF5C9

P921

Q30412709-85113877-E6C1-4348-BCEF-DBC30FC64FD8

P932

Q30412709-B357C9B5-D6FC-4161-A22E-F43AA204D297

P356

S12032-014-0971-Y

P1433

Medical Oncology

P1476

Long-term influence of chemotherapy on steatosis-associated advanced hepatic fibrosis.

@en

P2093

Ayse L Mindikoglu

http://www.w3.org/2001/XMLSchema#string

Barton F Lane

http://www.w3.org/2001/XMLSchema#string

Colleen Reilly

http://www.w3.org/2001/XMLSchema#string

H Richard Alexander

http://www.w3.org/2001/XMLSchema#string

Min Zhan

http://www.w3.org/2001/XMLSchema#string

Samer S El-Kamary

http://www.w3.org/2001/XMLSchema#string

Srinevas K Reddy

http://www.w3.org/2001/XMLSchema#string

William J Culpepper

http://www.w3.org/2001/XMLSchema#string

Yixing Jiang

http://www.w3.org/2001/XMLSchema#string

P2860

The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology

Steatohepatitis: a tale of two "hits"?

Noninvasive evaluation of hepatic fibrosis using acoustic radiation force-based shear stiffness in patients with nonalcoholic fatty liver disease

Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population

Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.

Endpoints and clinical trial design for nonalcoholic steatohepatitis.

Hepatotoxicity of chemotherapy.

Percutaneous ultrasonographically guided liver punctures: an analysis of 1961 patients over a period of ten years.

The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis.

Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures

P2888

s12032-014-0971-y

P304

971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0971-Y

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2014-05-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1038702019

http://www.w3.org/2001/XMLSchema#string

P698

24798875

http://www.w3.org/2001/XMLSchema#string

P921

P932

4419370

http://www.w3.org/2001/XMLSchema#string